Azetidine and piperidine compounds useful as PDE10 inhibitors
US9493459B2 · kind B2 · utility
0Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 2016 |
| Grant date | Nov 15, 2016 |
| Priority date | — |
| Expiry date | Mar 1, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Azetidine and piperidine compounds of formula (I):as defined in the specification, compositions containing them, and processes for preparing such compounds and intermediates thereof. Provided herein also are methods of treating cognitive disorders or diseases treatable by inhibition of PDE10, such as Huntington's Disease, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.